GlassScriptPhysician profile
Genea Wragg
NPI 1588296156
$1,758.62
in general payments reported to CMS, 2019-2025
22 companies · $587 in 2025
The $587 reported for 2025 was more than what 88% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $166 · 2023: $681 · 2024: $325 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,517 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,517.19 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $419.66 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $309.28 | 2022-2025 | |
| Hologic Sales and Service, LLC | $235.97 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Biogen, INC. | $125.00 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $113.10 | 2023-2025 | Accrufer |
| Abbvie INC. | $78.41 | 2022-2023 | |
| Optumhealth Care Solutions, LLC | $71.47 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Exeltis, USA INC. | $69.31 | 2024 | Slynd |
| Therapeuticsmd, INC. | $47.59 | 2022 | |
| Organon LLC | $34.83 | 2023 | Nexplanon |
| Sage Therapeutics, LLC | $31.08 | 2025 | Zurzuvae |
| Aspira Women'S Health INC | $28.71 | 2024 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $24.32 | 2022 | |
| Daiichi Sankyo INC. | $23.36 | 2024 | Injectafer |
| Evofem Biosciences, INC. | $23.23 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $21.60 | 2025 | Femlyv |
| Becton, Dickinson and Company | $21.58 | 2022 | |
| Gynesonics, INC. | $18.83 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exact Sciences Corporation | $17.79 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $16.35 | 2023 | |
| Supernus Pharmaceuticals, INC. | $13.85 | 2025 | Qelbree |
| Coopersurgical, INC. | $13.30 | 2024 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Genea Wragg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.